Impact of Adlay-Based Formula on Pain and Discomfort in Women with Dysmenorrhea: A Randomized Controlled Trial
Nutrients · 2024
DOI: 10.3390/nu16234026 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Yi-Fen Chiang und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan. Hauptthemen laut MEDLINE: Dysmenorrhea, Pain Measurement. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Taiwan Agricultural Research Institute Council of Agriculture, Executive Yuan, Translab International., Ltd. Taiwan.
Abstract (Originalsprache)
Background
Primary dysmenorrhea, a highly prevalent condition that significantly impacts women’s daily activities and quality of life, occurs without underlying pelvic pathological changes. Conventional treatments, such as warm water therapy, provide temporary relief; however, more effective interventions are needed. This study aimed to evaluate the effectiveness of an Adlay-based formula in reducing dysmenorrhea symptoms through randomized controlled trials.
Methods
A total of 69 participants were randomly assigned to either the Adlay-based formula group (n = 35) or the placebo group (n = 34). Baseline characteristics, including age, age of menarche, dysmenorrhea onset, menstrual duration, BMI, blood pressure, and heart rate, were comparable between groups. The primary outcomes were measured using the Visual Analogue Scale (VAS) for dysmenorrhea, pain assessment scales, the Menstrual Distress Questionnaire (MDQ), and serum levels of inflammatory biomarkers (PGE2, PGF2α, IL-6, Hs-CRP).
Results
The intervention group showed a significant reduction in VAS scores at both the first treatment and at the end of the study compared to baseline and the placebo group. Pain assessments indicated improvements in persistent pain, dull pain, exhaustion, nausea/vomiting, lower abdominal swelling, back pain, diarrhea, and cold sweats. Additionally, biomarker analysis revealed significant reductions in PGE2, PGF2α, and Hs-CRP levels in the intervention group, with no significant change in IL-6 levels.
Conclusions
The Adlay-based formula effectively alleviated dysmenorrhea symptoms, improved pain and discomfort, and reduced inflammatory biomarkers compared to placebo. These findings suggested that the formula could serve as a promising alternative for managing primary dysmenorrhea.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Nutrition and Health Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan.
- Clinical Pharmacy Department, Faculty of Pharmacy, Ain Shams University, Cairo 11566, Egypt.
- Department of Obstetrics and Gynecology, University of Chicago, Chicago, IL 60637, USA.
- Graduate Institute of Metabolism and Obesity Sciences, College of Nutrition, Taipei Medical University, Taipei 11031, Taiwan.
- School of Food Safety, Taipei Medical University, Taipei 11031, Taiwan.
- Nutrition Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan.
ORCID-Profile: Mohamed Ali, Shih-Min Hsia
Förderung
- Taiwan Agricultural Research Institute Council of Agriculture, Executive Yuan
- Translab International., Ltd. Taiwan
Zitieren
APA
Chiang, Y. F., Huang, K. C., Ali, M., & Hsia, S. M. (2024). Impact of Adlay-Based Formula on Pain and Discomfort in Women with Dysmenorrhea: A Randomized Controlled Trial. Nutrients. https://doi.org/10.3390/nu16234026
Vancouver
Chiang YF, Huang KC, Ali M, Hsia SM. Impact of Adlay-Based Formula on Pain and Discomfort in Women with Dysmenorrhea: A Randomized Controlled Trial. Nutrients. 2024. doi:10.3390/nu16234026
BibTeX
@article{Chiang2024,
author = {Chiang, Yi-Fen and Huang, Ko-Chieh and Ali, Mohamed and Hsia, Shih-Min},
title = {Impact of Adlay-Based Formula on Pain and Discomfort in Women with Dysmenorrhea: A Randomized Controlled Trial},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16234026}
}
EUVIMED